Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic™ self-expandable bioprosthetic valve-Reference-Cited by-同舟云学术

Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic™ self-expandable bioprosthetic valve

Published:2017-10-08 Issue:7 Volume:91 Page:1339-1344
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Htun Wah Wah¹²^ORCID,Grines Cindy³,Schreiber Theodore¹

Affiliation:

1. Department of Cardiology; Detroit Medical Center/Wayne State University; Detroit Michigan

2. Department of Cardiothoracic Surgery; Northwell Health, Lenox Hill Hospital; New York

3. Department of Cardiology; Northwell Health, North Shore University Hospital; Manhasset New York

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Reference12 articles.

1. Association between carotid and coronary artery disease in patients with aortic valve stenosis: an angiographic study;Antonini-Canterin;Angiology,2009

2. ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients with Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. Coronary Revascularization Writing Group;Patel;J Nucl Cardiol,2017

3. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardiothoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Intervention (EAPCI). Task Force on Myocardial Revascularization of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery; European Association of Percutaneous Cardiovascular Interventions;Eur J Cardiothorac Surg,2014

4. Impact of coronary artery disease on outcomes after transcatheter aortic valves implantation;Masson;Catheter Cardiovasc Interv,2010

5. Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation;Weaweser;Eurointervention,2011

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation and management of coronary artery disease in transcatheter aortic valve implantation candidates with severe aortic stenosis and coronary artery disease: technology and techniques;Expert Review of Medical Devices;2024-09-13

2. Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement: Feasibility in clinical practice;Revista Portuguesa de Cardiologia;2023-09

3. TAVR Interventions and Coronary Access: How to Prevent Coronary Occlusion;Life;2023-07-21

4. Management of coronary artery disease in patients with aortic stenosis in the era of transcatheter aortic valve replacement;Frontiers in Cardiovascular Medicine;2023-06-20

5. Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions in collaboration with the ESC Working Group on Cardiovascular Surgery;EuroIntervention;2023-05